ISSN: 2161-0711

Journal of Community Medicine & Health Education
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Community Med Health Educ,
  • DOI: 10.4172/2161-0711.1000718

Antiretroviral Treatment Monitoring and Factors Affecting Response to Treatment of HIV Patients in Massawa Hospital of Eritrea, Cross-Sectional Study, 2019

Berhe Tesfai*, Adhanom Debesai, Fitsum Kibreab, Zemui Mekonen, Mohammed Abruhum, Fnan Ghirmay and Mulugeta Russom
*Corresponding Author : Berhe Tesfai, Medical Department, Massawa Hospital, Email: berhetesfai04@gmail.com

Abstract

Background: Adherence to Antiretroviral therapy has been strongly correlated with HIV viral suppression, reduced rates of resistance, increased survival, and improved quality of life. The objective of this study was to evaluate antiretroviral treatment monitoring and determine the factors affecting response to treatment of HIV patients in Massawa hospital, Eritrea.
Methods: It was a cross sectional type with medical records review among HIV patients in Massawa antiretroviral therapy clinic. A checklist was used as data collection tool from patients and medical cards, from April 16 to June 23, 2019. Data was entered in CSPro 7.2 and analyzed by SPSS version 21. Results were presented in tables, chi-squared test and odds ratio. Ethical approval was obtained from Ministry of health research and ethical clearance committee of Eritrea, and written Consent was obtained from the patients.
Results: A total of 180 patients were enrolled in the study, dominated by females (74.4%) and Tigrigna ethnic group (71.7%). During starting antiretroviral treatment, 62.8% patients had CD4 level <200 cells/μl and were on clinical stages II (32.2%) and III (46.7%). The current CD4 and viral load level of most patients were above 500 cells/μl (52.8%) and undetectable (<40 copies/ml) in 75% of cases respectively. Furthermore; 98.3% of the patients were currently in clinical stage I. Patients with fair adherence had lower CD4 count (AOR=0.03, 95% CI=0.0-0.19) and viral load suppression (AOR=0.02, 95%CI=0.0-0.2). Nonsmokers were about two times and 37 times more likely to have a higher CD4 level and undetectable viral load <40 copies/ml when compared to smokers respectively.
Conclusion: Most patients’ current viral load was undetectable with increased CD4 count and improved clinical stage. Male gender and poor adherence was the main factors significantly associated with poor response to Antiretroviral Therapy. Further prospective studies with larger sample size are required.

Keywords: HIV; Antiretroviral therapy; viral load; Adherence; Virulogical failure; Immunological failure

Top